Literature DB >> 22187986

Clinical practice. Primary hyperparathyroidism.

Claudio Marcocci1, Filomena Cetani.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22187986     DOI: 10.1056/NEJMcp1106636

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  89 in total

1.  The changing pattern of diagnosing primary hyperparathyroidism in young patients.

Authors:  Irene Lou; David F Schneider; Rebecca S Sippel; Herbert Chen; Dawn M Elfenbein
Journal:  Am J Surg       Date:  2016-06-14       Impact factor: 2.565

Review 2.  Clinical aspects of primary hyperparathyroidism: clinical manifestations, diagnosis, and therapy.

Authors:  Rudolf Wolfgang Gasser
Journal:  Wien Med Wochenschr       Date:  2013-08-29

Review 3.  Epigenetic alterations in human parathyroid tumors.

Authors:  Chiara Verdelli; Irene Forno; Valentina Vaira; Sabrina Corbetta
Journal:  Endocrine       Date:  2015-02-27       Impact factor: 3.633

4.  Assessing the risk of hypercalcemic crisis in patients with primary hyperparathyroidism.

Authors:  Andrew J Lowell; Norah M Bushman; Xing Wang; Yue Ma; Susan C Pitt; Rebecca S Sippel; David F Schneider; Reese W Randle
Journal:  J Surg Res       Date:  2017-07-12       Impact factor: 2.192

5.  Hypercalciuria: its value as a predictive risk factor for nephrolithiasis in asymptomatic primary hyperparathyroidism?

Authors:  F Saponaro; F Cetani; L Mazoni; M Apicella; M Di Giulio; F Carlucci; M Scalese; E Pardi; S Borsari; J P Bilezikian; C Marcocci
Journal:  J Endocrinol Invest       Date:  2019-12-23       Impact factor: 4.256

6.  Ambulatory blood pressure monitoring-derived short-term blood pressure variability in primary hyperparathyroidism.

Authors:  A Concistrè; A Grillo; G La Torre; R Carretta; B Fabris; L Petramala; C Marinelli; A Rebellato; F Fallo; C Letizia
Journal:  Endocrine       Date:  2017-07-12       Impact factor: 3.633

7.  New role for ZFX in oncogenesis.

Authors:  Andrew Arnold; Chen-Pang Soong
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

8.  Italian Society of Endocrinology Consensus Statement: definition, evaluation and management of patients with mild primary hyperparathyroidism.

Authors:  C Marcocci; M L Brandi; A Scillitani; S Corbetta; A Faggiano; L Gianotti; S Migliaccio; S Minisola
Journal:  J Endocrinol Invest       Date:  2015-03-28       Impact factor: 4.256

9.  Predictors of renal function in primary hyperparathyroidism.

Authors:  Marcella D Walker; Thomas Nickolas; Anna Kepley; James A Lee; Chiyuan Zhang; Donald J McMahon; Shonni J Silverberg
Journal:  J Clin Endocrinol Metab       Date:  2014-02-14       Impact factor: 5.958

Review 10.  Primary hyperparathyroidism.

Authors:  John P Bilezikian; Natalie E Cusano; Aliya A Khan; Jian-Min Liu; Claudio Marcocci; Francisco Bandeira
Journal:  Nat Rev Dis Primers       Date:  2016-05-19       Impact factor: 52.329

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.